Informatie:
Fout:
ID
18407
Beschrijving
A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00087711
Link
https://clinicaltrials.gov/show/NCT00087711
Trefwoorden
Versies (1)
- 03-11-16 03-11-16 -
Geüploaded op
3 november 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Non Small Cell Lung Carcinoma NCT00087711
Eligibility Non Small Cell Lung Carcinoma NCT00087711
- StudyEvent: Eligibility
Similar models
Eligibility Non Small Cell Lung Carcinoma NCT00087711
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Non-Small Cell Lung Carcinoma | TNM clinical staging | Non-Small Cell Lung Carcinoma Amenable curative treatment
Item
diagnosis of nsclc stage iiib not amenable to curative treatment or stage iv.
boolean
C0007131 (UMLS CUI [1])
C3258246 (UMLS CUI [2])
C0007131 (UMLS CUI [3,1])
C3900053 (UMLS CUI [3,2])
C1273390 (UMLS CUI [3,3])
C3258246 (UMLS CUI [2])
C0007131 (UMLS CUI [3,1])
C3900053 (UMLS CUI [3,2])
C1273390 (UMLS CUI [3,3])
Prior Chemotherapy Malignant neoplasm of lung
Item
no prior chemotherapy for lung cancer.
boolean
C1514457 (UMLS CUI [1,1])
C0242379 (UMLS CUI [1,2])
C0242379 (UMLS CUI [1,2])
Measurable Lesion Linear Quantity
Item
patients must have at least one uni-dimensionally measurable lesion.
boolean
C1513041 (UMLS CUI [1,1])
C0205132 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0205132 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
prior radiation therapy Bone Marrow Percentage | Therapeutic radiology procedure Whole-Pelvis | Therapeutic radiology procedure Completed
Item
prior radiation therapy to less than 25% of bone marrow, whole pelvis not allowed. radiation must be completed at least 4 weeks prior to study enrollment.
boolean
C0279134 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C3827467 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C3827467 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
Drugs, Non-Prescription
Item
treatment with any drug within the last 30 days that has not received regulatory approval.
boolean
C0013231 (UMLS CUI [1])
Heart condition Serious
Item
serious cardiac condition.
boolean
C3842523 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,2])
Disease Serious In addition to Non-Small Cell Lung Carcinoma | Compliance behavior Limited
Item
serious medical disorder in addition to nsclc that would make it difficult for the patient to complete the study.
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0332287 (UMLS CUI [1,3])
C0007131 (UMLS CUI [1,4])
C1321605 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0205404 (UMLS CUI [1,2])
C0332287 (UMLS CUI [1,3])
C0007131 (UMLS CUI [1,4])
C1321605 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
Folic Acid Intake Unwilling | Vitamin B12 supplement Intake Unwilling
Item
inability or unwillingness to take folic acid or vitamin b12 supplementation.
boolean
C0016410 (UMLS CUI [1,1])
C1512806 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C3661610 (UMLS CUI [2,1])
C1512806 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
C1512806 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C3661610 (UMLS CUI [2,1])
C1512806 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
Body fluid retention | Drainage Unsuccessful
Item
presence of fluid retention that cannot be controlled by drainage.
boolean
C0268000 (UMLS CUI [1])
C0013103 (UMLS CUI [2,1])
C1272705 (UMLS CUI [2,2])
C0013103 (UMLS CUI [2,1])
C1272705 (UMLS CUI [2,2])